-       Report 
- January 2025
-  83 Pages 
- Global 
   From       €3500EUR$4,192USD£3,186GBP 
            -       Report 
- August 2025
-  150 Pages 
- Global 
   From       €2927EUR$3,273USD£2,575GBP 
      €3444EUR$3,850USD£3,029GBP 
            -       Report 
- August 2025
-  150 Pages 
- Global 
   From       €3003EUR$3,358USD£2,642GBP 
      €3533EUR$3,950USD£3,108GBP 
            -       Report 
- August 2025
-  150 Pages 
- Global 
   From       €3003EUR$3,358USD£2,642GBP 
      €3533EUR$3,950USD£3,108GBP 
            -       Report 
- August 2025
-  148 Pages 
- Global 
   From       €3155EUR$3,528USD£2,775GBP 
      €3712EUR$4,150USD£3,265GBP 
             -       Report 
- August 2025
-  144 Pages 
- Global 
   From       €3155EUR$3,528USD£2,775GBP 
      €3712EUR$4,150USD£3,265GBP 
            -       Report 
- August 2025
-  148 Pages 
- Global 
   From       €3155EUR$3,528USD£2,775GBP 
      €3712EUR$4,150USD£3,265GBP 
          -       Report 
- August 2025
-  148 Pages 
- Global 
   From       €2594EUR$2,900USD£2,282GBP 
          -       Report 
- August 2025
-  151 Pages 
- Global 
   From       €2594EUR$2,900USD£2,282GBP 
            -       Report 
- December 2024
-  150 Pages 
- Global 
   From       €3003EUR$3,358USD£2,642GBP 
      €3533EUR$3,950USD£3,108GBP 
          -       Clinical Trials 
- September 2025
-  94 Pages 
- Global 
   From       €3086EUR$3,450USD£2,714GBP 
          -       Report 
- September 2025
-  85 Pages 
- Global 
   From       €3126EUR$3,495USD£2,750GBP 
          -       Clinical Trials 
- August 2025
-  1403 Pages 
- Global 
   From       €3086EUR$3,450USD£2,714GBP 
          -       Report 
- August 2025
-  118 Pages 
- Global 
   From       €13412EUR$14,995USD£11,798GBP 
          -       Report 
- July 2025
-  89 Pages 
- Global 
   From       €8940EUR$9,995USD£7,864GBP 
          -       Report 
- April 2025
-  20 Pages 
- Global 
   From       €13412EUR$14,995USD£11,798GBP 
          -       Report 
- March 2025
-  114 Pages 
- Global 
   From       €13412EUR$14,995USD£11,798GBP 
          -       Clinical Trials 
- March 2025
-  52 Pages 
- Global 
   From       €3086EUR$3,450USD£2,714GBP 
          -       Clinical Trials 
- March 2025
-  289 Pages 
- Global 
   From       €3086EUR$3,450USD£2,714GBP 
          -       Clinical Trials 
- January 2025
-  47 Pages 
- Global 
   From       €3086EUR$3,450USD£2,714GBP 
       
       The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include    Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less   Read more